AOI Online Chat

Dr. Sainath Bhethanabhotla


Dr. Sainath.B

Consultant Medical Oncologist


DM- Thesis-

  • Outcome of pediatric Hodgkin lymphoma patients treated with ABVD in a tertiary care centre in India.
  • Prognostic significance of IL-6 expression by immunohistochemistry in pediatric Hodgkin lymphoma treated with ABVD chemotherapy.

MD-Thesis –

  • Role of Change of Position During Phototherapy in Management of Non-Haemolytic Hyperbilirubinemia in Late Preterm and Term Infants-Randomised Controlled Trial.
  • Won Sorel Catherine prize for Best post graduate in pediatrics for the year 2012.
  • Stood 2nd in NNF gold medal paper for the year 2012(1).
  • Received Scholarship for Oral presentation in SIOP-2015, Cape Town, South Africa for the abstract “OUTCOME OF PEDIATRIC HODGKIN LYMPHOMA TREATED WITH ABVD: A MULTICENTRIC ANALYSIS OF 335 PATIENTS”.
  • Awarded “Abstract achievement award” at American Society of Hematology Meeting on Hematological Malignancies held in Chicago on 16th,17th September 2016 for the abstract “Prognostic Significance of Neutrophil-Lymphocyte Ratio in Advanced Pediatric Hodgkin Lymphoma-A Multicentric Analysis of 186 patients”
  • Bhethanabhotla S, Bakhshi S. Reply: Neither post-treatment PET-CT nor interim PET-CT using Deauville criteria predicts outcome in pediatric Hodgkin lymphoma. J Nucl Med. Dec 8th 2016.
  • Bhethanabhotla S, Jain S, Kapoor G, Mahajan A, Chopra A, Vishnubhatla S. Outcome of pediatric advanced Hodgkin lymphoma treated with ABVD and predictors of inferior survival:-a multicenter study of 186 patients. Leuk Lymphoma – Dec 6th 2016.
  • Bakhshi S, Bhethanabhotla S, Kumar R, Agarwal K, Sharma P, Thulkar S, et al. Post-treatment PET-CT Rather than Interim PET-CT Using Deauville criteria Predicts Outcome in Pediatric Hodgkin Lymphoma-a Prospective Study Comparing PET-CT versus Conventional Imaging. J Nucl Med. Oct 6th 2016.
  • Bhethanabhotla S, Bakhshi S. Presence of risk factors does not affect outcome in early stage pediatric Hodgkin lymphoma treated with ABVD. Ann Hematol. 18th Nov 2016.
  • Taywade SK, Kumar R, Bhethanabhotla S, Bal C. Role of (18)F-FDG PET-CT in Monitoring the Cyclophosphamide Induced Pulmonary Toxicity in Patients with Breast Cancer – 2 Case Reports. Nucl Med Mol Imaging. Sept 2016;50(3):261–5.
  • Kakkar A, Rajeshwari M, Bhethanabhotla S, Kaur K, Jain D, Gogia A, et al. Primary diffuse large B-cell lymphoma of the prostate: A report of two cases with diagnostic considerations. J Cancer Res Ther. Dec 2015.
  • Gajendra S, Gogia A, Tanwar P, Sahoo MK, Bhethanabhotla S, Durgapal P, et al. Synchronous metastatic pulmonary adenocarcinoma with small cell lymphoma. Leuk Lymphoma. July 2014 ;55(7):1678–80.
  • Bhethanabhotla S, Thukral A, Sankar MJ, Agarwal R, Paul VK, Deorari AK. Effect of position of infant during phototherapy in management of hyperbilirubinemia in late preterm and term neonates: a randomized controlled trial. J Perinatol. Oct 2013.
  • Kumar L, Boya RR, Pai R, Harish P, Mookerjee A, Sainath B, et al. Autologous stem cell transplantation for multiple myeloma: Long-term results. The National Medical Journal of India. 1st July 2016.